Skip to main content
. 2022 Mar 31;16:807473. doi: 10.3389/fnins.2022.807473

FIGURE 3.

FIGURE 3

AppG–F mice suitable for studies of BACE1 inhibitors. The AppG–F line is devoid of the Swedish mutation that influences the β-secretase activity and elevates the quantity of CTFβ. (The AppG–F line instead carries a wild-type sequence: KM.) The AppG–F model would be appropriate for use in preclinical studies of β-secretase inhibitors without the interference of the Swedish mutation.